Intercept's $55M Payout In Stock-Drop MDL Gets Final OK
A New York federal judge on Thursday gave final approval to a $55 million payout from Intercept Pharmaceuticals Inc. to settle multidistrict litigation brought by investors accusing it of securities fraud...To view the full article, register now.
Already a subscriber? Click here to view full article